These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18855810)

  • 1. Comparing topiramate with naltrexone in the treatment of alcohol dependence.
    Baltieri DA; Daró FR; Ribeiro PL; de Andrade AG
    Addiction; 2008 Dec; 103(12):2035-44. PubMed ID: 18855810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients.
    Baltieri DA; Daró FR; Ribeiro PL; Andrade AG
    Drug Alcohol Depend; 2009 Nov; 105(1-2):33-41. PubMed ID: 19595518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial.
    Likhitsathian S; Uttawichai K; Booncharoen H; Wittayanookulluk A; Angkurawaranon C; Srisurapanont M
    Drug Alcohol Depend; 2013 Dec; 133(2):440-6. PubMed ID: 23906999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of full-dose ondansetron to treat heavy-drinking men withdrawing from alcohol in Brazil.
    Corrêa Filho JM; Baltieri DA
    Addict Behav; 2013 Apr; 38(4):2044-51. PubMed ID: 23396176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using topiramate or naltrexone for the treatment of alcohol-dependent patients.
    Flórez G; García-Portilla P; Alvarez S; Saiz PA; Nogueiras L; Bobes J
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1251-9. PubMed ID: 18482157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study).
    Morley KC; Kranzler HR; Luquin N; Baillie A; Shanahan M; Trent R; Teesson M; Haber PS
    Trials; 2018 Aug; 19(1):443. PubMed ID: 30115121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.
    Guardia J; Caso C; Arias F; Gual A; Sanahuja J; Ramírez M; Mengual I; Gonzalvo B; Segura L; Trujols J; Casas M
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1381-7. PubMed ID: 12351933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.
    Johnson BA; Ait-Daoud N; Akhtar FZ; Ma JZ
    Arch Gen Psychiatry; 2004 Sep; 61(9):905-12. PubMed ID: 15351769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials.
    Falk D; Wang XQ; Liu L; Fertig J; Mattson M; Ryan M; Johnson B; Stout R; Litten RZ
    Alcohol Clin Exp Res; 2010 Dec; 34(12):2022-34. PubMed ID: 20659066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate for the treatment of alcohol dependence: comparison with naltrexone.
    Flórez G; Saiz PA; García-Portilla P; Alvarez S; Nogueiras L; Bobes J
    Eur Addict Res; 2011; 17(1):29-36. PubMed ID: 20975274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of alcoholic beverage preference in the severity of alcohol dependence and adherence to the treatment.
    Baltieri DA; Daró FR; Ribeiro PL; De Andrade AG
    Alcohol; 2009 May; 43(3):185-95. PubMed ID: 19269773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
    Falk DE; O'Malley SS; Witkiewitz K; Anton RF; Litten RZ; Slater M; Kranzler HR; Mann KF; Hasin DS; Johnson B; Meulien D; Ryan M; Fertig J;
    JAMA Psychiatry; 2019 Apr; 76(4):374-381. PubMed ID: 30865232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone in the treatment of alcohol dependence.
    Krystal JH; Cramer JA; Krol WF; Kirk GF; Rosenheck RA;
    N Engl J Med; 2001 Dec; 345(24):1734-9. PubMed ID: 11742047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for the efficacy of naltrexone treatment in alcohol dependence: sweet preference.
    Laaksonen E; Lahti J; Sinclair JD; Heinälä P; Alho H
    Alcohol Alcohol; 2011; 46(3):308-11. PubMed ID: 21266377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients.
    Guardia J; Roncero C; Galan J; Gonzalvo B; Burguete T; Casas M
    Addict Behav; 2011 Mar; 36(3):265-9. PubMed ID: 21146937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.